AI-generated draft from CMS source. Review and verify clinical accuracy before use.
CLINICAL STAGE / CARE PATHWAY
Patient is currently in the therapeutic intervention phase of care for chronic vertebrogenic low back pain that has persisted for at least 6 months despite conservative management, with clinical and imaging findings supporting progression to thermal destruction of the intraosseous basivertebral nerve.
– Sequencing logic:
Thermal destruction of the intraosseous basivertebral nerve is considered after failure of non-surgical management including physical therapy, medication management, activity modification, and/or injection therapy. Imaging must demonstrate Modic type 1 or 2 changes correlating to the symptomatic vertebral levels, typically L3-S1.
ICD-10 / DIAGNOSIS SUPPORT
Diagnosis support includes vertebrogenic low back pain with appropriate Modic changes seen on MRI consistent with vertebral endplate degeneration and inflammation.
The documented diagnosis correlates with chronic lumbar pain symptoms, functional limitations, and imaging findings without evidence of radicular symptoms or alternate spinal pathology.
– Example ICD-10 options:
M54.51 – Vertebrogenic low back pain
M47.816 – Spondylosis without myelopathy or radiculopathy, lumbar region
M47.817 – Spondylosis without myelopathy or radiculopathy, lumbosacral region
SUBJECTIVE / HPI SUPPORT
Patient reports chronic midline low back pain described as a deep, aching, and burning sensation with intermittent electrical shock-type episodes. The pain worsens with spinal flexion, sitting, standing, and physical activity, and has resulted in decreased ability to perform activities of daily living and work tasks for greater than 6 months.
– Edit if needed:
greater than 12 weeks duration
no radicular symptoms
absence of lower extremity weakness or sensory deficits
CONSERVATIVE CARE / PRIOR TREATMENT
Patient has undergone at least 6 months of conservative care including physical therapy, physician-directed home exercise programs, activity modification, NSAID therapy, and at least one trial of injection therapy without sustained functional improvement or pain relief.
– Common conservative care examples:
Formal physical therapy
Chiropractic manipulation trial
Epidural or facet injection
Pharmacologic management with NSAIDs and muscle relaxants
– Documentation tip:
Include details about duration and types of conservative measures tried along with patient response.
OBJECTIVE / DIAGNOSTIC SUPPORT
Physical examination findings and review of MRI demonstrate Modic type 1 or type 2 changes at vertebral levels L3-S1, corresponding to patient’s clinical symptoms of vertebrogenic low back pain. There is no evidence of radiculopathy, spinal stenosis, fracture, tumor, infection, or other non-vertebrogenic pathology.
Neurological exam is negative for radicular signs or motor deficits.
Imaging confirms absence of significant lumbar disc extrusion greater than 5mm, spondylolisthesis over 2mm, facet arthrosis with effusion, or other exclusionary spinal abnormalities.
ASSESSMENT
Assessment: Chronic vertebrogenic low back pain secondary to vertebral endplate degeneration and inflammation as evidenced by Modic changes on MRI. Patient has persistent pain and functional impairment despite adequate conservative care. Clinical history, examination, and imaging findings support medical necessity for proceeding with thermal destruction of the intraosseous basivertebral nerve.
PLAN / NEXT STEP
Plan: Proceed with thermal destruction of the intraosseous basivertebral nerve targeting affected vertebrae between L3 and S1 based on persistent symptoms, diagnostic imaging correlation, and failed conservative management. Risks, benefits, and alternatives have been discussed with the patient.
– Edit if needed:
right-sided
left-sided
bilateral
lumbar levels L3-L5
lumbosacral level S1
PROCEDURE-SPECIFIC CLINICAL REQUIREMENTS
Patient meets criteria for BVN ablation including chronic lumbar pain greater than 6 months, failure of at least 6 months of non-surgical management, absence of contraindications such as radiculopathy or infection, and MRI evidence of Modic type 1 or 2 changes at appropriate lumbar or lumbosacral levels.
Thermal ablation will be performed under fluoroscopic guidance with radiofrequency energy applied at 85 degrees Celsius for approximately 15 minutes per treated vertebral body.
– Documentation tip:
Include baseline and expected follow-up pain scores, documentation of prior therapies tried, and MRI findings supporting vertebrogenic pain.
FOLLOW-UP / RESPONSE DOCUMENTATION
Patient’s follow-up evaluation shows meaningful improvement in pain intensity, function, standing and walking tolerance, sleep quality, and activities of daily living compared to pre-procedural baseline.
Pain relief and functional gains are clinically consistent with expected outcomes following intraosseous BVN ablation.
– Edit if needed:
greater than 50% improvement
sustained relief lasting several months
MISSING DOCUMENTATION CHECK
– Documentation items to confirm:
Symptom duration of 6 months or more
Functional limitation documented with pain or disability scale
Details of prior conservative care including duration and types
Baseline and post-procedure pain scores
Imaging confirming Modic type 1 or 2 changes at L3-S1
Physical exam excluding radiculopathy or other pathology
Levels and laterality targeted for ablation
Clinical diagnosis consistent with vertebrogenic low back pain
APPEAL / PEER-TO-PEER CLINICAL SUPPORT
The requested thermal destruction of the intraosseous basivertebral nerve is clinically supported by the documented diagnosis of vertebrogenic low back pain, chronic symptom duration, failed prior conservative treatments, and MRI evidence of Modic changes. This care pathway aligns with clinical guidelines and supports medical necessity for the proposed intervention to improve patient function and reduce pain.
Clinical record supports that BVN ablation is a reasonable next step for this patient’s chronic lumbar pain refractory to non-surgical care and correlates with imaging and exam findings.
– Common workflow:
Initial conservative management → diagnostic confirmation with MRI showing Modic changes → exclusion of radiculopathy or other pathologies → consideration of BVN ablation for chronic vertebrogenic pain refractory to conservative therapy.
COVERED PROCEDURES
– Thermal destruction (ablation) of the intraosseous basivertebral nerve (BVN) for vertebrogenic chronic low back pain (cLBP).
– CPT 64628 for first two vertebral bodies treated (lumbar or sacral), including all imaging guidance.
– CPT 64629 for each additional vertebral body treated, listed separately in addition to 64628.
– Up to 4 vertebral bodies treated in one procedure.
– Procedure performed under fluoroscopic imaging guidance with moderate/conscious sedation or general anesthesia.
COVERED DIAGNOSES
– Chronic lumbar low back pain (≥6 months) causing functional deficit.
– MRI evidence of Type 1 or Type 2 Modic changes (vertebral endplate inflammatory or fatty changes) at vertebral levels L3 to S1.
– ICD-10 examples: M54.51 (Vertebrogenic low back pain), M47.816, M47.817 (spondylosis without myelopathy/radiculopathy lumbar/lumbosacral).
MEDICAL NECESSITY REQUIREMENTS
– Documented failure of ≥6 months of conservative non-surgical management (e.g., physical therapy, chiropractic care, injection therapy, pharmacotherapy).
– Exclusion of non-vertebrogenic causes of pain by clinical/radiologic assessment (e.g., fracture, tumor, infection, significant deformity).
– Multidisciplinary evaluation including physical and psychological assessment, with clinical documentation in medical record.
– Baseline pain and disability scale assessment required before treatment for functional measurement.
LIMITATIONS AND CONTRAINDICATIONS
– Not covered in skeletally immature patients (≤18 years).
– Exclude patients with active infection, bleeding disorders, pregnancy, severe cardiac/pulmonary compromise.
– No coverage for primary radicular pain or symptomatic lumbar stenosis.
– History of prior lumbar/lumbosacral spine surgery at treatment level excludes coverage, except discectomy/laminectomy performed >6 months prior with resolved radicular pain.
– Exclude patients with osteoporosis (T-score ≤ -2.5), fragility fractures, spinal cancer, significant disc protrusion (>5mm), spondylolisthesis (>2mm), spondylolysis, facet arthrosis with facet pain.
– BMI >40 is exclusion.
– Active untreated substance abuse and severe systemic disease limiting quality-of-life improvements may preclude coverage.
FREQUENCY AND UTILIZATION
– Procedure is limited to once per vertebral body in a patient’s lifetime.
BILLING AND CODING GUIDANCE
– Use CPT 64628 for first two vertebral bodies treated; CPT 64629 for each additional vertebral body.
– Include all imaging guidance in procedure codes; do not separately bill imaging guidance codes.
– Follow Medicare claims processing requirements for complete and accurate data submission per Social Security Act §1833(e).
– Modifier usage not explicitly stated in source.
ANESTHESIA
– Moderate/conscious sedation or general anesthesia allowed during procedure.
DENIAL RISK AND COMMON TRIGGERS
– Lack of documentation of failed conservative treatment ≥6 months.
– Absence of Modic changes on MRI or improper imaging documentation.
– Presence of excluded diagnoses or prior disqualifying surgeries not documented or identified.
– Repeat procedures on same vertebral body.
– Incomplete documentation of multidisciplinary evaluation or baseline pain/disability score.
– Billing for imaging guidance separately from CPT 64628/64629.
DOCUMENTATION EXPECTATIONS
– Supportive clinical history including pain duration, intensity, and functional impact using a validated scale.
– Detailed documentation of conservative management methods and failure.
– MRI reports confirming Modic type 1 or 2 changes at L3-S1 levels.
– Multidisciplinary evaluations including psychological assessment with documented results.
– Procedure note documenting vertebral levels treated, sedation/anesthesia used, and imaging guidance performed.
PROVIDER QUALIFICATIONS
– Not clearly stated in source.
IMAGING
– MRI required to demonstrate Modic changes (Type 1 or 2) at corresponding vertebral levels prior to procedure.
RELATED REFERENCES
– LCD L40302 version 2 for thermal destruction of intraosseous BVN.
– CMS Medicare Claims Processing Manual, Chapter 13 and 23 regarding billing and NCCI compliance.
– Article A60324 provides billing and coding instructions aligned with LCD.
NOT CLEARLY STATED IN SOURCE
– Specific modifier use for procedure reporting.
– Detailed provider credential requirements.
– Exact frequency limits beyond once per vertebral body per lifetime mention.
– Requirements for preauthorization or other prior administrative steps.